NCT00997477View on ClinicalTrials.gov

Correct Use of Sequential Formoterol and Budesonide Inhaler Capsule Treatment Via Aerolizer and Patient Satisfaction in Asthmatics

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2010

Primary Completion Date

July 31, 2010

Conditions
Asthma
Interventions
DRUG

Foradil Combi (Formoterol-budesonide)

Trial Locations (4)

Unknown

Novartis Investigator Site, Ankara

Novarits Investigator Site, Istanbul

Novartis Investigator Site, Istanbul

Novartis Investigator Site, Izmir

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY